Nuclear targeting sequence
AssigneeMedTrain Technologies, LLC
InventorsAlbert J. Banes, Jie Qi
Life of this patent
Estimating the term…
Loading patent…
AssigneeMedTrain Technologies, LLC
InventorsAlbert J. Banes, Jie Qi
Estimating the term…
The present provides nuclear localization signaling (NLS) sequences derived from titin, comprised of amino acids 181-220: SVGRATSTAE LLVQGEEEVP AKKTKTIVST AQISESRQTR and fragments thereof, such as amino acids 193-208: VQGEEEVP AKKTKTIV; amino acids 199-208: VPAKKTKTIV; and amino acids 200-206: PAKKTKT. The NLS sequences can be linked to agents, such as peptides, proteins or nucleotides, for transporting the agents into the nucleus of cells, and the NLS-agent complex can be further linked to antibodies or ligands for specific binding to cells. Also provided is a method for constructing cDNAs comprising combining a NLS sequence with a nucleic acid sequence for a target protein for expression and entry of the target protein into the nucleus of cells, which then can perform specific functions therein.
A method for transporting a target protein into the nucleus of a cell in vitro, comprising introducing into a cell a composition comprising a nuclear localization signaling (NLS) sequence consisting of the amino acid sequence of SEQ ID NO:
Dependencies are inferred from the claim text.